Global Hip Replacement Market– Driver
Development in Product launch
Product launch create a great impact on Global Hip Replacement Market but development in launched products create a greater impact on Global Hip Replacement Market. For instance, on October 9, 2021, Microport, a medical device company in China, orthopedics receives 510(k) approval from US Food and Drug Administration (FDA) for marketing in U.S. for two hip products which are Dynasty Dual Mobility Acetabular Liners and the E-Class Vitamin E Blended Dual Mobility Inserts. The Dynasty Dual Mobility Acetabular Cup System is an artificial joint designed and developed to mimic the physiological anatomy of the human hip joint. Polyethylene material mixed with vitamin E can prevent oxidation of the acetabular cup liner and increase wear resistance. It is especially recommended for elderly people with hip fractures or revision hip replacements requiring repair surgery, and for patients with neuromuscular disease have high risk of dislocation.
Global Hip Replacement Market: Restraint
Complications associated with hip replacement
Complications are expected to hinder the growth of the global hip replacement market. The complications such as total hip surgery Dislocation, Periprosthetic Fracture, Aseptic Loosening, Wound Complications, Prosthetic Joint Infection. For instance, an article published by National Centre for Biotechnology Information (NCBI) on September 4, 2022 states that approximately 70% of total hip replacement occur in the first month after the index operation. The overall incidence is about 1% to 3%. Risk factors include: Previous hip surgery (most important independent risk factor for dislocation), Elderly (over 70 years), Misalignment of components: excessive anteversion causes anterior displacement and excessive retroversion causes posterior displacement, Neuromuscular disorders/disorders (eg Parkinson's disease), Drug/alcohol abuse.
Global Hip Replacement Market: Key Developments
On December 10, 2021, The first hip replacement procedure performed using the MicroPort AnteriorPath hip surgical technique was successfully completed in Brazil, according to a announcement from MicroPort Orthopaedics, a orthopaedic equipment and technologies based company. AnteriorPath is an anterior, portal-assisted technique for hip replacement that is intended to encourage patient early rehabilitation and hasten the patient's return to full function.
On December 9, 2020, DePuy Synthes, part of the Johnson & Johnson Medical Devices Company, launched the Kincise surgical automated system.This system automates implant assembly, bone preparation and positioning in hip replacement. Kincise surgical automated system is intended to take the place of the handheld surgical mallet used in total hip replacement treatments. This should result in more consistent clinical outcomes as well as a reduction in the wear and tear on the surgeon's body from manual procedures with the surgical mallet, which can contribute to work-related injuries.
Hip Replacement Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients